Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Optimizing platelet transfusion therapy.

Joanna Mary Heal1, Neil Blumberg

  • 1Hematology-Oncology Unit, Department of Medicine, University of Rochester Medical Center, 601 Elwood Avenue, Box 608, Rochester, NY 14642, USA.

Blood Reviews
|June 9, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prophylactic half-dose platelet transfusion effect on thrombocytopenia, transfusion, and bleeding occurrence in patients with hematologic disease.

American journal of clinical pathology·2026
Same author

The case for washing red blood cells and platelets - A concise review of donors, processes, and products.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2026
Same author

The case against infusing ABO incompatible antibody and antigen from all blood components.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2026
Same author

Whole Blood versus Components for Transfusion in Trauma and Life-Threatening Hemorrhage-Unresolved Issues.

Anesthesia and analgesia·2026
Same author

The case for universal leukoreduction of blood transfusions.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2025
Same author

Differences in outcomes associated with ABO blood groups in recipients of IVIG.

Blood vessels, thrombosis & hemostasis·2025
Same journal

Treating large B-cell lymphoma: Current strategies and unmet needs across community and academic settings.

Blood reviews·2026
Same journal

MRD in multiple myeloma: Moving from "minimal" to "measurable".

Blood reviews·2026
Same journal

PRISMA-based systematic review on iron stores in repeat blood donors.

Blood reviews·2026
Same journal

Artificial intelligence applications in thrombotic thrombocytopenic Purpura: A systematic review of diagnostic, risk stratification, and prognostic models.

Blood reviews·2026
Same journal

Antibacterial, antifungal and antiviral prophylaxis and vaccination strategies in adult patients with acute myeloid and promyelocytic leukemia: An expert panel consensus from the GIMEMA group.

Blood reviews·2026
Same journal

The Lebanese national patient blood management guidelines: A new page in the medical practice.

Blood reviews·2026
See all related articles

Prophylactic platelet transfusions are widely used but lack proven benefit. Randomized trials show similar outcomes for different transfusion triggers and sources, highlighting the need for further research on bacterial contamination and transfusion thresholds.

Area of Science:

  • Hematology
  • Transfusion Medicine

Background:

  • Platelet transfusions are a common supportive therapy.
  • Prophylactic platelet transfusions are used in thrombocytopenic patients without bleeding, but their efficacy and safety lack robust evidence from randomized trials.
  • Current practices often lack definitive evidence-based guidelines.

Purpose of the Study:

  • To review evidence from randomized trials on platelet transfusion strategies.
  • To evaluate the safety and efficacy of different prophylactic transfusion triggers and platelet sources.
  • To assess the benefits of leukoreduction and ABO matching in platelet transfusions.

Main Methods:

  • Systematic review of randomized controlled trials (RCTs) comparing different platelet transfusion strategies.
  • Analysis of data on transfusion triggers, platelet sources (apheresis vs. whole blood-derived), leukoreduction, and ABO compatibility.

Related Experiment Videos

  • Inclusion of preliminary observational studies on clinical outcomes.

    • Main Results:

    • RCTs demonstrate equivalence between transfusion triggers of 10,000/microl and 20,000/microl, with the lower threshold potentially offering safety and resource benefits.
    • RCTs show equivalence between apheresis-derived and whole blood-derived platelets, with apheresis reducing infectious risk and whole blood being more cost-effective.
    • Leukoreduced and ABO-identical platelets reduce risks of HLA alloimmunization, transfusion refractoriness, transfusion reactions, and CMV transmission.

    Conclusions:

    • Evidence supports the equivalence of various platelet transfusion strategies, suggesting potential for optimizing patient safety and resource utilization.
    • Leukoreduction and ABO matching are proven to reduce specific transfusion complications.
    • Future research should focus on bacterial contamination and optimal prophylactic transfusion thresholds for specific patient populations, such as surgical or invasive procedure candidates.